In the present investigation, the fixed-dose combination (FDC) tablet of Atorvastatin calcium and Ezetimibe was prepared by a quality-by-design approach using two-level factorial design.
Aspi13 - Stock.adobe.com
In the present investigation, the fixed-dose combination (FDC) tablet of Atorvastatin calcium and Ezetimibe was prepared by a quality-by-design approach using 23 factorial design. Precompression and post-compression parameters were determined indicating excellent flow properties of granules as well as good tableting characteristics of the final tablets. Dissolution study showed higher drug release nearly 80% within 30 min for all prepared batches attributed to conversion from crystalline to amorphous form of the drug. ANOVA studies revealed that there was a linear correlation between the predicted, and the observed responses gave higher values of r2, indicating excellent fitting of the model (P < 0.001). Thus, the prepared FDC tablet executed a good relationship between selected critical formulation parameters and critical quality attributes. The drug release rate obtained met the selected dissolution criteria.
Click here for a PDF of this article.Submitted: August 5, 2020.
Accepted: October 12, 2020.
Rajendra Kotadiya,* rajendrakotadiya.ph@charusat.ac.in; +91 8160701232, is assistant professor, Krunal Jasani is PG student, and Gayatri Patel is professor, all at Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology (CHARUSAT), Changa, Gujarat, India.
*To whom all correspondence should be addressed.
Pharmaceutical Technology
Vol. 45, No. 6
June 2021
Pages: 34-42
When referring to this article, please cite it as Rajendra Kotadiya, Krunal Jasani, and Gayatri Patel, “Using Quality by Design to Develop Fixed-Dose Combination Tablets,” Pharmaceutical Technology 45 (6) 2021.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.